Drug Discovery Services Industry Size, Growth, Global Value, Share Analysis by Top Market Key Players | Comprehensive Report by MRFR

“Drug Discovery Services Market”
Drug Discovery Services Market Growth Register at a CAGR over 10% to 2023. Analysis By Types of Services: Drug Metabolism & Pharmacokinetics (DMPK) Services, Pharmaceutical Services, Medicinal Chemistry, and Biological Services and others

Drug Discovery Services Market Outlook 2019 to 2023

Acknowledging the ascending graph of the growth, the market is climbing constantly, Market Research Future (MRFR), in its recently published study report foretells that the global frozen pizza market will grow rapidly by 2023, registering a CAGR over 10% during the forecast period (2017 to 2023).

The Global Drug Discovery Services Market is growing at a rapid pace; mainly due to the burgeoning healthcare sector.  The market is predominantly driven by the augmented demand and supply for the medicines, the generic drugs, and the growing number of patents expires.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/5870  

Drug Discovery Services refer to as the outsourcing the process of development of a new medicine. These services minimize the costs and timelines of drug discovery. The most common methods employed for drug discoveries are molecular manipulation, drug metabolites, random screening, molecular designing, and serendipity.

Industry Segmentation

By Drug Type: Small Molecule Drug, and Biologics.

By Types of Services: Drug Metabolism & Pharmacokinetics (DMPK) Services, Pharmaceutical Services, Medicinal Chemistry, and Biological Services and others.

By Therapeutic Area: Oncology, Neurology, Cardiovascular Diseases, Respiratory Diseases, and Diabetes among others.

By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, and Candidate Validation among others.

By Technology: High Throughput Screening, Biochips, Pharmacogenomics & Pharmacogenetics, Combinatorial Chemistry, Nanotechnology, Spectroscopy, and Metabolomics among others.

By End-user:  Hospitals & Clinics, Pharmaceutical Companies, Biotechnology Companies, and Research Institutes, among others.

By Regions:  Europe, North America, APAC and the Rest-of-the-World.

Competitive Analysis by Major Key Players

Some of the players leading the market include Advinus Therapeutics, Abbott Laboratories Inc., Agilent Technologies Ubiquigent, AstraZeneca PLC, Albany Molecular Research Inc. (AMRI), Aurigene, Charles River Laboratories International, Bayer AG, ChemBridge Corporation, Eli Lilly and Company, Covance, Evotec, GE Healthcare, Domainex, F. Hoffmann-La Roche Ltd, GlaxoSmithKline LLC, GenScript, GVK Biosciences, Lonza, Jubilant Biosys, Merck, Piramal Enterprises, Pharmaceutical Product Development, LLC (PPD), Promega Corporation, Shimadzu Corp., Selcia Limited, SRI International, Thermo Fisher Scientific, Syngene International Ltd., Viva Biotech, and WuXi AppTec.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/drug-discovery-services-market-5870  

Comprehensive Regional Analysis

Globally the North American region dominates the drug discovery services market heading with the increasing consumption of medicines. This market is projected to grow at a strong CAGR, creating a large revenue pocket by the end of the review period. This is due to around the world. Also, factors such as the increasing prevalence of chronic diseases, high healthcare expenditures, and augmenting demand for the novel drug discoveries substantiates the growth of the drug discovery services market in the North American Region.

The European region accounts for the second-largest market for drug discovery services which is expected to grow at a considerable CAGR. The financial support by the government for research and development alongside the patent expiration of various blockbuster drugs are estimated to drive the drug discovery services market in the region. Furthermore, the burgeoning pharmaceutical industry fosters the growth of the regional market.

The Asia Pacific region is rapidly emerging as a promising market for drug discovery services owing to the availability of cost-competitive skilled workforce and raw materials. Factors such as the huge developments in the pharmaceutical sector, demand for breakthrough drug discoveries, and huge patient pool propels the market growth in the region.

Avail Discount at https://www.marketresearchfuture.com/check-discount/5870  

Industry/ Innovation/ Related News:

November 27, 2018 – Cyclica Inc. (Canada), a leading provider of bioinformatics and computational systems biology solutions for the pharmaceutical industry announced its collaboration with Bayer AG (Germany), a multinational pharmaceutical and life sciences company to advance drug discovery. The collaboration will involve looking further into polypharmacological profiles of small molecules.

November 07, 2018 – Genesis Drug Discovery & Development (US), a contract research organization (CRO) contract research organization (CRO) announced its partnership with the Yale University (US), a private Ivy League research university to strengthen its drug discovery services.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.


Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/drug-discovery-services-market-5870